412 related articles for article (PubMed ID: 8892641)
1. IL-12 enhances vaccine-induced immunity to schistosomes by augmenting both humoral and cell-mediated immune responses against the parasite.
Wynn TA; Reynolds A; James S; Cheever AW; Caspar P; Hieny S; Jankovic D; Strand M; Sher A
J Immunol; 1996 Nov; 157(9):4068-78. PubMed ID: 8892641
[TBL] [Abstract][Full Text] [Related]
2. Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni.
Hoffmann KF; James SL; Cheever AW; Wynn TA
J Immunol; 1999 Jul; 163(2):927-38. PubMed ID: 10395689
[TBL] [Abstract][Full Text] [Related]
3. Schistosoma mansoni: protective immunity in IL-4-deficient mice.
King CL; Malhotra I; Jia X
Exp Parasitol; 1996 Nov; 84(2):245-52. PubMed ID: 8932774
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Th1- and Th2-associated immune reactivities stimulated by single versus multiple vaccination of mice with irradiated Schistosoma mansoni cercariae.
Caulada-Benedetti Z; al-Zamel F; Sher A; James S
J Immunol; 1991 Mar; 146(5):1655-60. PubMed ID: 1671579
[TBL] [Abstract][Full Text] [Related]
5. IL-12 enhances vaccine-induced immunity to Schistosoma mansoni in mice and decreases T helper 2 cytokine expression, IgE production, and tissue eosinophilia.
Wynn TA; Jankovic D; Hieny S; Cheever AW; Sher A
J Immunol; 1995 May; 154(9):4701-9. PubMed ID: 7722323
[TBL] [Abstract][Full Text] [Related]
6. Optimal vaccination against Schistosoma mansoni requires the induction of both B cell- and IFN-gamma-dependent effector mechanisms.
Jankovic D; Wynn TA; Kullberg MC; Hieny S; Caspar P; James S; Cheever AW; Sher A
J Immunol; 1999 Jan; 162(1):345-51. PubMed ID: 9886405
[TBL] [Abstract][Full Text] [Related]
7. Induction of Th1 cell-mediated protective immunity to Schistosoma mansoni by co-administration of larval antigens and IL-12 as an adjuvant.
Mountford AP; Anderson S; Wilson RA
J Immunol; 1996 Jun; 156(12):4739-45. PubMed ID: 8648120
[TBL] [Abstract][Full Text] [Related]
8. Elevated expression of Th1 cytokines and nitric oxide synthase in the lungs of vaccinated mice after challenge infection with Schistosoma mansoni.
Wynn TA; Oswald IP; Eltoum IA; Caspar P; Lowenstein CJ; Lewis FA; James SL; Sher A
J Immunol; 1994 Dec; 153(11):5200-9. PubMed ID: 7525727
[TBL] [Abstract][Full Text] [Related]
9. The debate over the effector function of eosinophils in helminth infection: new evidence from studies on the regulation of vaccine immunity by IL-12.
Wynn TA
Mem Inst Oswaldo Cruz; 1997; 92 Suppl 2():105-8. PubMed ID: 9698921
[TBL] [Abstract][Full Text] [Related]
10. T-helper type-1-dominated lymph node responses induced in C57BL/6 mice by optimally irradiated cercariae of Schistosoma mansoni are down-regulated after challenge infection.
Pemberton RM; Wilson RA
Immunology; 1995 Feb; 84(2):310-6. PubMed ID: 7751008
[TBL] [Abstract][Full Text] [Related]
11. Monoclonal antibody to IFN-gamma modifies pulmonary inflammatory responses and abrogates immunity to Schistosoma mansoni in mice vaccinated with attenuated cercariae.
Smythies LE; Coulson PS; Wilson RA
J Immunol; 1992 Dec; 149(11):3654-8. PubMed ID: 1431135
[TBL] [Abstract][Full Text] [Related]
12. In vivo effects of monoclonal anti-L3T4 antibody on immune responsiveness of mice infected with Schistosoma mansoni. Reduction of irradiated cercariae-induced resistance.
Kelly EA; Colley DG
J Immunol; 1988 Apr; 140(8):2737-45. PubMed ID: 3128606
[TBL] [Abstract][Full Text] [Related]
13. ICAM-1 and iNOS expression increased in the skin of mice after vaccination with gamma-irradiated cercariae of Schistosoma mansoni.
Ramaswamy K; He YX; Salafsky B
Exp Parasitol; 1997 Jun; 86(2):118-32. PubMed ID: 9207742
[TBL] [Abstract][Full Text] [Related]
14. Defective vaccine-induced resistance to Schistosoma mansoni in P strain mice. III. Specificity of the associated defect in cell-mediated immunity.
James SL; Deblois LA; Al-Zamel F; Glaven J; Langhorne J
J Immunol; 1986 Dec; 137(12):3959-67. PubMed ID: 3097138
[TBL] [Abstract][Full Text] [Related]
15. Induction of protective immunity against Schistosoma mansoni by a nonliving vaccine. II. Response of mouse strains with selective immune defects.
James SL; DeBlois LA
J Immunol; 1986 May; 136(10):3864-71. PubMed ID: 3084645
[TBL] [Abstract][Full Text] [Related]
16. Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.
Sun JB; Mielcarek N; Lakew M; Grzych JM; Capron A; Holmgren J; Czerkinsky C
J Immunol; 1999 Jul; 163(2):1045-52. PubMed ID: 10395703
[TBL] [Abstract][Full Text] [Related]
17. Schistosoma mansoni ex vivo lung-stage larvae excretory-secretory antigens as vaccine candidates against schistosomiasis.
El Ridi R; Tallima H
Vaccine; 2009 Jan; 27(5):666-73. PubMed ID: 19056448
[TBL] [Abstract][Full Text] [Related]
18. IL-10 inhibits parasite killing and nitrogen oxide production by IFN-gamma-activated macrophages.
Gazzinelli RT; Oswald IP; James SL; Sher A
J Immunol; 1992 Mar; 148(6):1792-6. PubMed ID: 1541819
[TBL] [Abstract][Full Text] [Related]
19. Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response.
Chiaramonte MG; Mentink-Kane M; Jacobson BA; Cheever AW; Whitters MJ; Goad ME; Wong A; Collins M; Donaldson DD; Grusby MJ; Wynn TA
J Exp Med; 2003 Mar; 197(6):687-701. PubMed ID: 12642601
[TBL] [Abstract][Full Text] [Related]
20. TNF is essential for the cell-mediated protective immunity induced by the radiation-attenuated schistosome vaccine.
Street M; Coulson PS; Sadler C; Warnock LJ; McLaughlin D; Bluethmann H; Wilson RA
J Immunol; 1999 Oct; 163(8):4489-94. PubMed ID: 10510391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
